In a time of increasingly individualized healthcare, Elizabeth Philp has become a significant force of innovation, especially in the fast-evolving field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the forefront of a movement to make bespoke medications more obtainable, disrupting the standard one-size